ES417157A1 - Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. - Google Patents
Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.Info
- Publication number
- ES417157A1 ES417157A1 ES417157A ES417157A ES417157A1 ES 417157 A1 ES417157 A1 ES 417157A1 ES 417157 A ES417157 A ES 417157A ES 417157 A ES417157 A ES 417157A ES 417157 A1 ES417157 A1 ES 417157A1
- Authority
- ES
- Spain
- Prior art keywords
- cultures
- virus
- mutants
- strains
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7226337A FR2201876B1 (US20030199744A1-20031023-C00003.png) | 1972-07-21 | 1972-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES417157A1 true ES417157A1 (es) | 1976-03-01 |
Family
ID=9102179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES417157A Expired ES417157A1 (es) | 1972-07-21 | 1973-07-21 | Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. |
Country Status (12)
-
1972
- 1972-07-21 FR FR7226337A patent/FR2201876B1/fr not_active Expired
-
1973
- 1973-07-16 IL IL42749A patent/IL42749A0/xx unknown
- 1973-07-16 ZA ZA734817A patent/ZA734817B/xx unknown
- 1973-07-20 JP JP48082428A patent/JPS4980229A/ja active Pending
- 1973-07-20 DE DE19732337134 patent/DE2337134A1/de not_active Withdrawn
- 1973-07-20 BE BE133744A patent/BE802649A/xx unknown
- 1973-07-20 DD DD172401A patent/DD107719A5/xx unknown
- 1973-07-20 GB GB3461773A patent/GB1443958A/en not_active Expired
- 1973-07-20 CA CA177,015A patent/CA1030872A/en not_active Expired
- 1973-07-20 CH CH1066973A patent/CH613229A5/xx not_active IP Right Cessation
- 1973-07-20 NL NL7310127A patent/NL7310127A/xx not_active Application Discontinuation
- 1973-07-21 ES ES417157A patent/ES417157A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2201876B1 (US20030199744A1-20031023-C00003.png) | 1975-11-28 |
| AU5817173A (en) | 1975-01-23 |
| CA1030872A (en) | 1978-05-09 |
| IL42749A0 (en) | 1973-10-25 |
| GB1443958A (en) | 1976-07-28 |
| ZA734817B (en) | 1974-06-26 |
| BE802649A (fr) | 1974-01-21 |
| FR2201876A1 (US20030199744A1-20031023-C00003.png) | 1974-05-03 |
| CH613229A5 (en) | 1979-09-14 |
| JPS4980229A (US20030199744A1-20031023-C00003.png) | 1974-08-02 |
| NL7310127A (US20030199744A1-20031023-C00003.png) | 1974-01-23 |
| DE2337134A1 (de) | 1974-02-14 |
| DD107719A5 (US20030199744A1-20031023-C00003.png) | 1974-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Carp et al. | A comparison of the replication cycles of simian virus 40 in human diploid and African green monkey kidney cells | |
| Wigand et al. | Neutralization of the adenoviruses types 1 to 28: specificity and antigenic relationships | |
| ES553758A0 (es) | Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia. | |
| ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
| ES417157A1 (es) | Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. | |
| Beard | Infectious bronchitis virus interference with Newcastle disease virus in monolayers of chicken kidney cells | |
| ES432385A1 (es) | Un metodo de obtener una cepa de virus de la gripe. | |
| ES430415A1 (es) | Un procedimiento para preparar una vacuna de virus de la gripe atenuado. | |
| Medill-Brown et al. | Mutation and selection pressure during adaptation of influenza virus to mice | |
| CN107603957B (zh) | 一种高效扩增j亚群禽白血病病毒的方法 | |
| ES8105930A1 (es) | Procedimiento para la preparacion de vacunas de virus poli- valentes | |
| Holness et al. | Separation within the Homologous Series of n-Alkyl Sulphates, n-Alkyl Pyridium and n-Alkyl Trimethyl Ammonium Halides by Paper Chromatography | |
| Yang et al. | Development of ELISA kits for antibodies against avian reovirus using the σC and σB proteins expressed in the methyltropic yeast Pichia pastoris | |
| Cole et al. | Maturation of envelope‐specific antibody responses to linear determinants in monkeys inoculated with attenuated SIV | |
| DK0592636T3 (da) | Fremgangsmåde til fremstilling af en levedygtig cellekultur, der er inficeret med en med dissemineret sklerose forbundet vi | |
| Reimann | Bacterial Type Transformation: Micrococcus tetragenus Infection. IV | |
| Burnet et al. | Reversion to virulence in an influenza virus mutant. | |
| FR2235704A2 (en) | Advanced strains of influenza virus - obtd. by repeated culturing in presence of a serum | |
| Cairns | The limited growth of influenza viruses in the mouse brain. | |
| Low et al. | Formation of Incomplete Influenza Virus in Ascites Tumor Cells: Studies on Complement-Fixing “S” Antigen | |
| GB1481650A (en) | Chemical processes and products | |
| Saturno et al. | Factors influencing determination of antigenic relationships between western equine encephalomyelitis virus strains | |
| Cossart | Marker studies of poliovirus | |
| Payne | Select bibliography on influenza | |
| Hirst | Antigenic Variation Among Influenza Viruses |